XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
OPERATING ACTIVITIES    
Net income $ 47,096 $ 78,195
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 14,142 15,198
Non-cash interest charges 66 66
Provisions for losses on trade and other accounts receivable 3,854 3,199
Gains on sales/disposals of operating property (248) (1,140)
Deferred income taxes, net (1,259) 758
Stock-based compensation 1,724 1,852
Changes in operating assets and liabilities:    
Decrease in trade and other accounts receivable 18,871 67,776
Decrease in other assets 11,574 8,625
Decrease in accounts payable (11,713) (37,068)
Increase in other liabilities 10,497 2,640
Decrease in insurance claims (396) (1,066)
NET CASH PROVIDED BY OPERATING ACTIVITIES 94,208 139,035 Close
INVESTING ACTIVITIES    
Sales and maturities of investments 19,923 40,349
Purchases of investments (15,869) (31,425)
Purchases of operating property (9,281) (6,233)
Proceeds from sales of operating property 1,585 1,645
NET CASH (USED) PROVIDED BY INVESTING ACTIVITIES (3,642) 4,336 Close
FINANCING ACTIVITIES    
Decrease in cash overdraft (9,867) (26,758)
Dividends paid (83,235) (82,660)
Proceeds from exercises of stock options 0 28
Taxes paid in lieu of shares issued related to stock-based compensation plans (3,060) (8,236)
Purchases of common stock 0 (15,433)
Principal payments on finance lease obligations (7,239) (9,408)
NET CASH USED BY FINANCING ACTIVITIES (103,401) (142,467) Close
Effect of exchange rate changes on cash and cash equivalents (537) 502 Close
(Decrease) increase in cash and cash equivalents (13,372) 1,406 Close
Cash and cash equivalents at beginning of period 481,043 339,581
Cash and cash equivalents at end of period $ 467,671 $ 340,987